Keyphrases
Near-infrared Spectroscopy
100%
Very Preterm Infants
100%
Brain Injury
100%
Randomized Clinical Trial
38%
Cerebral Oxygenation
22%
Risk of Bias
22%
Low Risk
16%
Cerebral Injury
11%
Clinical Outcomes
11%
Random Error
11%
Embase
5%
Cochrane
5%
Needs Assessment
5%
Review Authors
5%
Cystic Periventricular Leukomalacia
5%
All-cause Mortality
5%
Adverse Events
5%
Neurological Outcome
5%
Neurodevelopmental Outcome
5%
Extracted Data
5%
Retinopathy of Prematurity
5%
Diagnostic Methods
5%
Renal Impairment
5%
MEDLINE
5%
PubMed
5%
Neurodevelopmental Impairment
5%
Chronic Lung Disease
5%
Appropriate Responses
5%
Conference Proceedings
5%
Data Quality
5%
Inclusion Criteria
5%
Infant Risk
5%
Search Strategy
5%
Risk Assessment
5%
Cochrane Central Register of Controlled Trials
5%
Search Methods
5%
Extremely Preterm Infants
5%
Selection Criteria
5%
Necrotizing Enterocolitis
5%
Clinical Database
5%
Mortality Event
5%
CINAHL
5%
Design Errors
5%
Intraventricular Hemorrhage
5%
Serious Adverse Events
5%
Clinical Analysis
5%
Term-equivalent Age
5%
Intervention Group
5%
Preterm Infants
5%
Patent Ductus Arteriosus
5%
Air Leak
5%
Nursing and Health Professions
near Infrared Spectroscopy
100%
Brain Injury
100%
Practice Guideline
33%
Oxygenation
22%
Random Error
11%
Systematic Review
11%
Clinical Outcome
11%
Adverse Event
11%
Patent Ductus Arteriosus
5%
Leukomalacia
5%
Cochrane Library
5%
All Cause Mortality
5%
Brain Hemorrhage
5%
Embase
5%
CINAHL
5%
Diagnosis
5%
Retrolental Fibroplasia
5%
Medline
5%
Sequential Analysis
5%
Chronic Lung Disease
5%
Necrotizing Enterocolitis
5%
Medicine and Dentistry
near Infrared Spectroscopy
100%
Brain Injury
100%
Randomized Clinical Trial
33%
Adverse Event
11%
Systematic Review
11%
All Cause Mortality
5%
Clinical Study
5%
Necrotizing Enterocolitis
5%
Sequential Analysis
5%
Retinopathy of Prematurity
5%
Chronic Lung Disease
5%
Leukomalacia
5%
Needs Assessment
5%
Clinical Trial
5%
Diagnosis
5%
Bleeding
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infrared Spectroscopy
100%
Brain Injury
100%
Randomized Clinical Trial
33%
Adverse Event
11%
Clinical Study
5%
Leukomalacia
5%
Necrotizing Enterocolitis
5%
All Cause Mortality
5%
Chronic Lung Disease
5%
Retrolental Fibroplasia
5%
Brain Hemorrhage
5%
Patent Ductus Arteriosus
5%
Clinical Trial
5%